UT Horizon Fund
UT Horizon Fund is a strategic venture capital fund that invests in early- and middle-stage companies.
Business Model:
Revenue: $16.7M
Employees: 2-10
Rankings
Industries / Tags:
Detailed UT Horizon Fund Information
Geographic Data
Address: 702 Colorado St Suite 6 620
City: Austin
State: TX
Zip: 78701
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Twitter
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Founded in 2012, the UT Horizon Fund is the strategic fund of the University of Texas System. Based on cutting edge research at UT System institutions, the UT Horizon Fund works with entrepreneurs and the investment community to help translate innovations out of UT to practical use. The UT Horizon Fund is evergreen where returns are re-invested for future growth and development.
Contact Phone:
+15124994495
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 8/2016 | Alafair Biosciences | Series A | 0 |
| 12/2015 | MicroTransponder | Series C | 0 |
| 5/2013 | PLx Pharma | Venture Round | 8.3M |
| 8/2014 | Apollo Endosurgery | Series C | 60.7M |
| 12/2012 | Emtora Biosciences | Seed Round | - |
| 9/2013 | MicroTransponder | Venture Round | 3.4M |
| 2/2014 | Aeglea BioTherapeutics | Series A | 0 |
| 12/2011 | Cerevast Therapeutics | Series C | 6.6M |
| 5/2015 | Admittance Technologies | Series A | 3.9M |
| 5/2016 | Decisio Health | Series B | 0 |
| 6/2017 | GenXComm | Seed | 1.5M |
| 3/2015 | Aeglea BioTherapeutics | Series B | 44M |
| 2/2013 | FibeRio | Series C | 13M |
| 10/2013 | Lynx Laboratories | Seed Round | - |
| 6/2018 | Astrocyte Pharmaceuticals | Seed Round | 0 |
| 3/2017 | Astrocyte Pharmaceuticals | Seed Round | 0 |
| 4/2014 | M87 | Series A | 0 |
| 11/2017 | Cardiovate | Seed | 1M |
| 1/2013 | Cardiovate | Seed Round | - |
| 2/2015 | M87 | Series B | 3M |
| 1/2013 | M87 | Convertible Note | - |
| 6/2017 | Lung Therapeutics | Series B | 14.3M |
| 6/2018 | Cerebri AI | Series A | 5M |
| 7/2013 | Lung Therapeutics | Convertible Note | - |
| 9/2015 | Lung Therapeutics | Series A | 2.6M |
| 9/2013 | EMIT Corporation | Series A | - |
| 12/2019 | Cerebri AI | Convertible Note | 0 |
| 5/2015 | Decisio Health | Convertible Note | - |
| 12/2017 | GenXComm | Series A | 7M |
| 6/2018 | Cerebri AI | Funding Round | 5M |
| 10/2012 | latakoo | Convertible Note | 550k |
| 7/2013 | Emtora Biosciences | Convertible Note | - |
| 7/2014 | Molecular Match | Venture Round | - |
| 12/2019 | Cerebri AI | Convertible Note | 0 |
| 6/2018 | Astrocyte Pharmaceuticals | Seed Round | 0 |
| 12/2017 | GenXComm | Series A | 0 |
| 11/2017 | Cardiovate | Seed Round | 0 |
| 6/2017 | GenXComm | Seed Round | 0 |
| 6/2017 | Lung Therapeutics | Series B | 0 |
| 3/2017 | Astrocyte Pharmaceuticals | Seed Round | 0 |
| 8/2016 | Alafair Biosciences | Series A | 0 |
| 5/2016 | Decisio Health | Series B | 0 |
| 12/2015 | MicroTransponder | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
